EP3625368
Aðferðir til að meta hættu á þróun ágengrar fjölhreiðra innlyksuheilabólgu af völdum John Cunningham-veiru með erfðarannsóknum
:
EP einkaleyfi í gildi á Íslandi:
8.8.2019:
9.11.2022:
19765344.7
:
14.12.2022:
15.1.2023
:
7.8.2039:
7.8.2025:
31.8.2025
:
METHODS FOR ASSESSING THE RISK OF DEVELOPING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY CAUSED BY JOHN CUNNINGHAM VIRUS BY GENETIC TESTING
8.8.2019
9.11.2022
14.12.2022
15.1.2023
7.8.2025
:
PML Screening, LLC:
23 Corporate Plaza, Suite 150, Newport Beach, CA 92660, US
:
Université Paris-Saclay:
Parc Technologique, Immeuble Discovery Route de l'Orme aux Merisiers - RD 128, 91190 Saint-Aubin, FR
:
The Assistance Publique - Hôpitaux de Paris (APHP):
149 rue de Sèvres, 75015 Paris, FR
:
The Institut National de la Santé et de la Recherche Médicale (INSERM):
101 rue Tolbiac, 75654 Paris Cedex 13, FR
:
HATCHWELL, Eli:
New York, NY 10036, US
:
EIS, Peggy S.:
New York, NY 10036, US
:
SMITH, Edward B., III:
New York, NY 10036, US
:
TAOUFIK, Yassine:
75014 Paris, FR
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201862716072 P:
8.8.2018:
US
:
201862716183 P:
8.8.2018:
US
:
US2019045721:
8.8.2019
:
C12Q 1/6883
: 5
: 28.7.2023
: 7.8.2024
: Árnason Faktor ehf.
: 6
: 14.8.2024
: 7.8.2025
: Árnason Faktor ehf.